Chris Cuvelier's most recent trade in Arcadia Biosciences Inc was a trade of 100,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on May 17, 2021.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Arcadia Biosciences Inc | Chris Cuvelier | Chief Growth Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2021 | 100,000 | 100,000 | - | - | Stock Option (right to buy) |